A Structured Knowledge Platform for Peptide Research
Categorised guides, compound monographs, mechanism references and laboratory methodology — an educational architecture that future releases will populate with peer-reviewed scientific content.
Categories
- Research Guides
Structured, evidence-based guides for researchers working with peptide reference standards in vitro.
OPEN - Compound Reference
Structured monographs covering identity, receptor targets, mechanisms and laboratory notes for each research peptide.
OPEN - SOONMechanisms of Action
Receptor-level and signalling-level explanations of how classes of research peptides act in vitro.
OPEN - SOONLaboratory Methodology
Handling, reconstitution, storage, HPLC purity and mass spectrometry procedures for peptide reference material.
OPEN - Scientific Literature
Curated references, citations and third-party publications underlying our guides and compound monographs.
OPEN - Comparisons
Side-by-side comparisons of compounds, receptor selectivity profiles and handling considerations.
OPEN - FAQs
Answers to common operational, quality and compliance questions about our reference material.
OPEN - Glossary
Definitions of the scientific terminology used across the Research Hub and compound monographs.
OPEN
How to read the Research Hub
- STEP 1Start HereOrient yourself in the Research Hub
- STEP 2MechanismUnderstand the receptor pathway
- STEP 3CompoundRead the compound monograph
- STEP 4Laboratory MethodConfirm handling and analytical procedure
- STEP 5ComparisonContrast with related compounds
- STEP 6Related ReadingContinue with linked guides and literature
- Tirzepatide FAQ
Comprehensive research-focused FAQ on Tirzepatide — identity, dual-receptor pharmacology, structural modifications, pharmacokinetics, laboratory handling, evidence base and regulatory status.
- Tirzepatide Mechanism of Action
Receptor-level explanation of Tirzepatide as a dual GIP / GLP-1 receptor agonist — dual cAMP / PKA signalling, biased β-arrestin engagement at GLP-1R, GIP-adipocyte biology and integrated satiety signalling.
- What is Tirzepatide?
Beginner-friendly research-focused introduction to Tirzepatide — a dual GIP / GLP-1 receptor agonist positioned between Semaglutide and Retatrutide in incretin pharmacology.
- Incretin Effect Explained
Foundation guide to the incretin effect — how GLP-1 and GIP amplify glucose-dependent insulin secretion, the physiology of gut L- and K-cells, and how incretin biology underpins GLP-1 receptor agonist research.